SRC and glioblastoma: We have previously shown that TAT-Cx43266-283, by inhibiting c-Src, reverses the stem cell phenotype [10], impairs migration, invasion [14], and metabolic plasticity [21] of GSCs, without affecting healthy brain cells, and improves survival of GBM mice models [22].